Cargando…
Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report
Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine.
Autores principales: | Seyedi, Saba, Navid, Shadan, Saadatian, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477723/ https://www.ncbi.nlm.nih.gov/pubmed/37675411 http://dx.doi.org/10.1002/ccr3.7872 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two
por: Razzaq, Azhar Kareem, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021) -
Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Publicado: (2021) -
Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Garnier, Matthieu, et al.
Publicado: (2021)